These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8538979)

  • 1. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1994.
    Pillans PI; Coulter DM
    N Z Med J; 1995 Nov; 108(1012):488-91. PubMed ID: 8538979
    [No Abstract]   [Full Text] [Related]  

  • 2. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1993.
    Pillans PI; Coulter DM
    N Z Med J; 1994 Nov; 107(990):490-3. PubMed ID: 7970369
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug associated hepatic reactions in New Zealand: 21 years experience.
    Pillans PI
    N Z Med J; 1996 Aug; 109(1028):315-9. PubMed ID: 8816722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Welsh Adverse Drug Reactions Scheme: experience of a UK regional monitoring centre.
    Houghton JE; Pinto Pereira LM; Woods FJ; Richens A; Routledge PA
    Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):93-107. PubMed ID: 8836315
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients.
    Seeger JD; Kong SX; Schumock GT
    Pharmacotherapy; 1998; 18(6):1284-9. PubMed ID: 9855328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-related deaths in a university central hospital.
    Juntti-Patinen L; Neuvonen PJ
    Eur J Clin Pharmacol; 2002 Oct; 58(7):479-82. PubMed ID: 12389071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Centre for Adverse Reactions Monitoring report for the period 1 July, 1994 to 3 June, 1996.
    Pillans P
    N Z Med J; 1997 Oct; 110(1053):383-5. PubMed ID: 9364188
    [No Abstract]   [Full Text] [Related]  

  • 9. International monitoring for adverse drug reactions of long latency.
    Fletcher AP; Griffin JP
    Adverse Drug React Toxicol Rev; 1991; 10(4):209-30. PubMed ID: 1793771
    [No Abstract]   [Full Text] [Related]  

  • 10. [Active drug monitoring of adverse drug reactions in pediatric emergency department].
    Planchamp F; Nguyen KA; Vial T; Nasri S; Javouhey E; Gillet Y; Ranchin B; Villard F; Floret D; Cochat P; Gueyffier F; Kassaï B;
    Arch Pediatr; 2009 Feb; 16(2):106-11. PubMed ID: 19117738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reaction monitoring in Jena--experiences of a regionalized pharmacovigilance centre.
    Hoffmann A; Hippius M; Sicker T
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):453-7. PubMed ID: 9784022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center)].
    Ciorciaro C; Hartmann K; Kuhn M
    Schweiz Med Wochenschr; 1998 Feb; 128(7):254-8. PubMed ID: 9540150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Zealand Committee on Adverse Drug Reactions. Fourth Annual Report.
    N Z Med J; 1969 Aug; 70(447):118-22. PubMed ID: 5258881
    [No Abstract]   [Full Text] [Related]  

  • 14. New Zealand Committee on adverse drug reactions: sixteenth annual report 1981.
    McQueen EG
    N Z Med J; 1982 Apr; 95(705):230-3. PubMed ID: 6953361
    [No Abstract]   [Full Text] [Related]  

  • 15. New Zealand committee on adverse drug reactions. Fifth annual report.
    N Z Med J; 1970 Aug; 72(459):128-33. PubMed ID: 5274202
    [No Abstract]   [Full Text] [Related]  

  • 16. Medication-related adverse reactions and the elderly: a literature review.
    Atkin PA; Shenfield GM
    Adverse Drug React Toxicol Rev; 1995; 14(3):175-91. PubMed ID: 7492703
    [No Abstract]   [Full Text] [Related]  

  • 17. Rethinking the numbers on adverse drug reactions.
    Lexchin J
    CMAJ; 1999 May; 160(10):1432. PubMed ID: 10352628
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse drug reaction surveillance in an emergency room.
    Stoukides CA; D'Agostino PR; Kaufman MB
    Am J Hosp Pharm; 1993 Apr; 50(4):712-4. PubMed ID: 8470691
    [No Abstract]   [Full Text] [Related]  

  • 19. New Zealand Committee on Adverse Drug Reactions: Seventeenth Annual Report, 1982.
    McQueen EG
    N Z Dent J; 1983 Jul; 79(357):81-6. PubMed ID: 6579410
    [No Abstract]   [Full Text] [Related]  

  • 20. [Retrospective study of adverse drug reactions in the elderly: experience of regional center for pharmacovigilance].
    Bruneau S; Bruhat C; Lagarce L; Lainé-Cessac P
    Therapie; 2001; 56(6):785-91. PubMed ID: 11878111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.